GlassScriptPhysician profile
Richard M Gilmore
NPI 1609842814
$45,459.02
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,963 · 2020: $1,810 · 2021: $20K · 2022: $17K · 2023: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $300 · Food and Beverage: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $300.00 |
| Food and Beverage | $262.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $24,817.22 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $7,548.26 | 2019-2023 | Farxiga |
| Pfizer INC. | $5,372.62 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $4,165.49 | 2019-2023 | Eliquis |
| Boston Scientific Corporation | $745.15 | 2019-2023 | Watchman Access System |
| Novartis Pharmaceuticals Corporation | $469.66 | 2019-2023 | |
| Abbott Laboratories | $456.46 | 2019-2022 | |
| Amarin Pharma, INC. | $256.01 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $201.08 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $174.00 | 2021-2022 | |
| Biosense Webster, INC. | $165.92 | 2022-2023 | Carto 3 |
| Janssen Pharmaceuticals, INC | $154.92 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $108.28 | 2019-2022 | |
| Amgen INC. | $99.03 | 2019-2022 | |
| Heartflow, INC. | $93.73 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $84.16 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $76.68 | 2022 | |
| Abiomed | $72.95 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $65.91 | 2019-2023 | Uptravi, Opsumit |
| Medtronic, INC. | $52.84 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $48.52 | 2019 | |
| Philips North America LLC | $46.35 | 2022 | |
| Intuitive Surgical, INC. | $38.89 | 2023 | Da Vinci Surgical System |
| United Therapeutics Corporation | $30.47 | 2019 | |
| Silk Road Medical, INC. | $25.98 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $25.07 | 2021-2022 | |
| Cardiovascular Systems INC. | $24.47 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $14.58 | 2020 | |
| Irhythm Technologies, INC. | $13.29 | 2019 | |
| Gilead Sciences, INC. | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Gilmore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.